Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV prophylactic vaccination strategies
Background Human papilloma virus (HPV) prevalence studies performed in different regions and populat...
Introduction: Cervical cancer is one of the leading causes of cancer in women worldwide. Cervical ca...
INTRODUCTION: Data on epidemiology of HPV infection are needed for the development of human papillo...
Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV pro...
Thesis (Master's)--University of Washington, 2017-06Background: Human Papillomavirus (HPV) infection...
Background: Despite a reduction in the prevalence of vaccine-preventable types of human papillomavir...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
Antibodies directed against the human papillomavirus (HPV) L1 protein are detected in approximately ...
Human papillomavirus (HPV) vaccines are available in the United States and around the world to preve...
BackgroundHuman papillomavirus (HPV) vaccine was recommended in 2006 for routine vaccination of US f...
Background: Cervical cancer is the fourth most common cancer in incidence and the first genital canc...
HUMAN PAPILLOMAVIRUS(HPV) is estimated to be themost common sexuallytransmitted infection in the Uni...
Thesis (Master's)--University of Washington, 2014Objective: To estimate high-risk (hr) HPV seropreva...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
OBJECTIVE: To estimate the prevalence and seroprevalence of high-risk human papillomavirus (HPV) in ...
Background Human papilloma virus (HPV) prevalence studies performed in different regions and populat...
Introduction: Cervical cancer is one of the leading causes of cancer in women worldwide. Cervical ca...
INTRODUCTION: Data on epidemiology of HPV infection are needed for the development of human papillo...
Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV pro...
Thesis (Master's)--University of Washington, 2017-06Background: Human Papillomavirus (HPV) infection...
Background: Despite a reduction in the prevalence of vaccine-preventable types of human papillomavir...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
Antibodies directed against the human papillomavirus (HPV) L1 protein are detected in approximately ...
Human papillomavirus (HPV) vaccines are available in the United States and around the world to preve...
BackgroundHuman papillomavirus (HPV) vaccine was recommended in 2006 for routine vaccination of US f...
Background: Cervical cancer is the fourth most common cancer in incidence and the first genital canc...
HUMAN PAPILLOMAVIRUS(HPV) is estimated to be themost common sexuallytransmitted infection in the Uni...
Thesis (Master's)--University of Washington, 2014Objective: To estimate high-risk (hr) HPV seropreva...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
OBJECTIVE: To estimate the prevalence and seroprevalence of high-risk human papillomavirus (HPV) in ...
Background Human papilloma virus (HPV) prevalence studies performed in different regions and populat...
Introduction: Cervical cancer is one of the leading causes of cancer in women worldwide. Cervical ca...
INTRODUCTION: Data on epidemiology of HPV infection are needed for the development of human papillo...
DOI
Add to ORKG